J.P. Morgan Notebook Day 1: Tax Reform At Last, Allergan's Job Cuts, Teva Turnaround, Biogen's Cash, And Getting FDA-Friendly
The Pink Sheet - In this article, The Pink Sheet covers the opening day of the JP Morgan Healthcare conference and notes comments by Catalyst’s President on the impact of new leadership under Commissioner Scott Gottlieb at FDA. During a panel at a the concurrently held Biotech Showcase, “Nancy Bradish Myers, president and founder of Catalyst Healthcare